FDA Inspection
Rechon Life Science ABRechon Life Science AB – FDA Inspection, Jun 29, 2018
Record Details
This FDA Inspection record concerns Rechon Life Science AB, with an inspection on June 29, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 1410a4ff-1c00-409f-b826-3e23ffac83f2
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1060687
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Rechon Life Science AB
7| Date | Classification | Office | Project area |
|---|---|---|---|
| September 6, 2024 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 17, 2023 | Not classified | Office of Inspections and Investigations | |
| November 27, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 2, 2016 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| April 29, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Rechon Life Science AB
- FDA Inspection 1251480 - 2024-09-06
- FDA Inspection 1201600 - 2023-03-17
- FDA Inspection 1125627 - 2019-11-27
- FDA Inspection 983550 - 2016-06-02
- FDA Inspection 969057 - 2016-04-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.